HLN

Congress Trades

Name	Value	Action	Amount Range	Price	Current Price
Valerie HoyleDemocrat $8.0k OtherSep 23, 2025 $1k-$15k -- $9.32

News

businesswire.comHaleon Invests in India to Deliver Better Everyday Health to Rural Communitiesbusinesswire.comJun 8

businesswire.comHaleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.businesswire.comJun 4

seekingalpha.comHaleon plc (HLN) Presents at 23rd annual dbAccess Global Consumer Conference Transcriptseekingalpha.comJun 3

prnewswire.comTUMS Kicks Off the "TUMS Food Match Cup," a Celebration of Global Soccer Fandom and Food Love Through Bold Flavor Mashupsprnewswire.comJun 3

zacks.comLCUT vs. HLN: Which Stock Is the Better Value Option?zacks.comMay 29

Trade HLN

About Haleon plc

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

CEO: Brian James McNamara
IPO Date: Jul 25, 2022

Market Data

Open: $8.96
High: $9.13
Low: $8.94
Volume: 8.9M
52W High: $11.28
52W Low: $8.65

Valuation

Market Cap: $40B
Enterprise Value: $37B

Financials

Free Cash Flow: $2.0B
Revenue: $11B
Net Income: $1.6B
Cash: $1.3B
Debt: $8.6B

Events

EarningsJul 30

EPS est. 0.278